Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
published in: PLOS MEDICINE
date of publication: 2016-12-06
language: English
main subject: phase II clinical trial, inflammatory breast cancer
Cites articles 80
- 2014-10-16
Date
Title
Article - wd:Q28554790